Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. Announces Extension of Expiration Date of the Tender Offer for Its Common Shares
DaVita Inc. today announced that it has extended its previously announced offer to purchase up to 20,000,000 of its common shares for ten business days, until 9:00 a.m., New York City time, on…
-
DaVita Announces Development Concerning the Company’s Florida Laboratory
DaVita Inc. announced that it received a letter today from First Coast Service Options, Inc., the Medicare carrier for the Company’s Florida laboratory, informing the Company of a change in the…
-
Amgen Raises EPOGEN Pricing
DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective April 25, 2002 at 5:01 PM Pacific Time. This pricing…
-
DaVita Announces Closing of Note Tender Offer
DaVita Inc. today announced that it has completed its tender offer for all of its outstanding 91/4% Senior Subordinated Notes due 2011. The note tender offer was originally announced on March 21,…
-
DaVita Revises Purchase Price in Tender Offer and Consent Solicitation for Its 9.25% Senior Subordinated Notes Due 2011
DaVita Inc. today revised the previously announced consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is…